Summary of the offering

Subscription period: 4 – 18 October.

Issue price: 5.85 SEK per share.

Subscription post: The minimum subscriptionpost is 860 shares (SEK 5,031).

Volume of Issuance and minimum execution limit: The offer includes a maximum of 4,444,444 shares, corresponding to SEK 25,999,997.40. The minimum limit for the right issue is SEK 16,999,994.70.

Number of shares before the issue: 7,463,207 shares.

Valuation (pre-money): Approximately 43.7 m SEK.

Subscriptions: The company has received presubscriptions of approximately 18.5 m SEK, total of approximately 71 percent of the issue volume.

Listing on Spotlight Stock Market: Scandion Oncology’s share is scheduled to be listed on Spotlight Stock Market. The first day of trading is scheduled to commence on November 8, 2018

ISIN: DK0061031895.

Important information regarding the offering 

The information that you can obtain by reading or downloading the offering on this website constitutes only a copy of the printed material (the “Material”). The Material and the offering are not addressed to natural or legal persons whose participation requires additional prospectuses, registration measures or measures other than those under Swedish and Danish law. As a result, the Material and offer may not be distributed in any country where the distribution or offer requires further action or is in violation of the laws and regulations of such country. It is the responsibility of every investor to observe such restrictions. The offering and the Material are addressed to the public in Sweden and Denmark. Any dispute regarding the offer or content of the Material shall be settled under Swedish law and by Swedish courts exclusively.